Â¥
21.75
Dec 25
Business Description
Shanghai Pharmaceuticals Holding Co Ltd
NAICS : 446110
ISIN : CNE000000C82
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.85 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.71 | |||||
Debt-to-EBITDA | 5.71 | |||||
Interest Coverage | 6 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.11 | |||||
Beneish M-Score | -2.36 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.5 | |||||
3-Year EBITDA Growth Rate | -7 | |||||
3-Year EPS without NRI Growth Rate | -10.2 | |||||
3-Year FCF Growth Rate | -23.1 | |||||
3-Year Book Growth Rate | 5.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 21.47 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.22 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.24 | |||||
9-Day RSI | 51.54 | |||||
14-Day RSI | 53.34 | |||||
6-1 Month Momentum % | 14.09 | |||||
12-1 Month Momentum % | 30.49 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.34 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 53.83 | |||||
Days Sales Outstanding | 105.68 | |||||
Days Payable | 87.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.27 | |||||
Dividend Payout Ratio | 0.39 | |||||
3-Year Dividend Growth Rate | 11.5 | |||||
Forward Dividend Yield % | 2.27 | |||||
5-Year Yield-on-Cost % | 3.22 | |||||
3-Year Average Share Buyback Ratio | -9.2 | |||||
Shareholder Yield % | -4.73 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 11.21 | |||||
Operating Margin % | 3.5 | |||||
Net Margin % | 1.48 | |||||
FCF Margin % | 1.17 | |||||
ROE % | 5.78 | |||||
ROA % | 1.85 | |||||
ROIC % | 7.02 | |||||
ROC (Joel Greenblatt) % | 16.62 | |||||
ROCE % | 9.55 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 19.91 | |||||
Forward PE Ratio | 14.17 | |||||
PE Ratio without NRI | 17.32 | |||||
Shiller PE Ratio | 14.79 | |||||
Price-to-Owner-Earnings | 53.06 | |||||
PEG Ratio | 4.46 | |||||
PS Ratio | 0.29 | |||||
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 1.5 | |||||
Price-to-Free-Cash-Flow | 26.37 | |||||
Price-to-Operating-Cash-Flow | 14.39 | |||||
EV-to-EBIT | 10.41 | |||||
EV-to-Forward-EBIT | 9.03 | |||||
EV-to-EBITDA | 10.41 | |||||
EV-to-Forward-EBITDA | 7.08 | |||||
EV-to-Revenue | 0.34 | |||||
EV-to-Forward-Revenue | 0.26 | |||||
EV-to-FCF | 28.61 | |||||
Price-to-Projected-FCF | 1.03 | |||||
Price-to-DCF (Earnings Based) | 1.52 | |||||
Price-to-DCF (FCF Based) | 2.31 | |||||
Price-to-Median-PS-Value | 0.94 | |||||
Price-to-Graham-Number | 1.08 | |||||
Price-to-Net-Current-Asset-Value | 3.86 | |||||
Earnings Yield (Greenblatt) % | 9.61 | |||||
FCF Yield % | 4.47 | |||||
Forward Rate of Return (Yacktman) % | 2.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Pharmaceuticals Holding Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 272,415.508 | ||
EPS (TTM) (Â¥) | 1.08 | ||
Beta | 0.64 | ||
Volatility % | 25.79 | ||
14-Day RSI | 53.34 | ||
14-Day ATR (Â¥) | 0.492898 | ||
20-Day SMA (Â¥) | 21.603 | ||
12-1 Month Momentum % | 30.49 | ||
52-Week Range (Â¥) | 15.36 - 23.2 | ||
Shares Outstanding (Mil) | 3,707.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Pharmaceuticals Holding Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Pharmaceuticals Holding Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shanghai Pharmaceuticals Holding Co Ltd Frequently Asked Questions
What is Shanghai Pharmaceuticals Holding Co Ltd(SHSE:601607)'s stock price today?
When is next earnings date of Shanghai Pharmaceuticals Holding Co Ltd(SHSE:601607)?
Does Shanghai Pharmaceuticals Holding Co Ltd(SHSE:601607) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |